Recently stock market analysts have updated their consensus ratings on shares of Cara Therapeutics Inc (CARA). The latest broker reports which are currently outstanding on Monday 9th of May state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 analysts “neutral”, 0 analysts “sell” and 0 analysts “strong sell”.

Most recent broker ratings

04/21/2016 – Cara Therapeutics Inc had its “overweight” rating reiterated by analysts at Piper Jaffray. They now have a USD 23 price target on the stock.

03/11/2016 – Cara Therapeutics Inc had its “buy” rating reiterated by analysts at Janney Montgomery Scott. They now have a USD 18 price target on the stock.

02/29/2016 – Cara Therapeutics Inc had its “buy” rating reiterated by analysts at Laidlaw. They now have a USD 17 price target on the stock.

02/26/2016 – Cara Therapeutics Inc had its “buy” rating reiterated by analysts at Cantor Fitzgerald. They now have a USD 28 price target on the stock.

02/26/2016 – Cara Therapeutics Inc had its “buy” rating reiterated by analysts at Needham & Company. They now have a USD 27 price target on the stock.

11/12/2015 – Cara Therapeutics Inc had its “buy” rating reiterated by analysts at Canaccord Genuity. They now have a USD 30 price target on the stock.

03/03/2015 – Cara Therapeutics Inc was upgraded to “buy” by analysts at MLV & Co. They now have a USD 26 price target on the stock.

12/09/2014 – Summer Street began new coverage on Cara Therapeutics Inc giving the company a “buy” rating. They now have a USD 20 price target on the stock.

02/25/2014 – Stifel Nicolaus began new coverage on Cara Therapeutics Inc giving the company a “buy” rating. They now have a USD 21 price target on the stock.

Cara Therapeutics Inc has a 50 day moving average of 6.54 and a 200 day moving average of 10.65. The stock’s market capitalization is 151.40M, it has a 52-week low of 4.26 and a 52-week high of 23.61.

The share price of the company (CARA) was down -0.18% during the last trading session, with a high of 5.99 and the volume of Cara Therapeutics Inc shares traded was 579329.

View other investors thoughts on Cara Therapeutics Inc on our new Stock Talk discussion platform. Sign up for free to contribute to the community and view research provided from other investors for any stock listed on the LSE, NYSE or NASDAQ.